233 related articles for article (PubMed ID: 29520103)
1. Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression.
Li K; Zhang TT; Wang F; Cui B; Zhao CX; Yu JJ; Lv XX; Zhang XW; Yang ZN; Huang B; Li X; Hua F; Hu ZW
Oncogene; 2018 May; 37(22):2967-2981. PubMed ID: 29520103
[TBL] [Abstract][Full Text] [Related]
2. Metformin reduces TRIB3 expression and restores autophagy flux: an alternative antitumor action.
Li K; Zhang TT; Hua F; Hu ZW
Autophagy; 2018; 14(7):1278-1279. PubMed ID: 29929422
[TBL] [Abstract][Full Text] [Related]
3. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.
Li K; Wang F; Cao WB; Lv XX; Hua F; Cui B; Yu JJ; Zhang XW; Shang S; Liu SS; Yu JM; Han MZ; Huang B; Zhang TT; Li X; Jiang JD; Hu ZW
Cancer Cell; 2017 May; 31(5):697-710.e7. PubMed ID: 28486108
[TBL] [Abstract][Full Text] [Related]
4. TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation.
Li K; Wang F; Yang ZN; Zhang TT; Yuan YF; Zhao CX; Yeerjiang Z; Cui B; Hua F; Lv XX; Zhang XW; Yu JJ; Liu SS; Yu JM; Shang S; Xiao Y; Hu ZW
Nat Commun; 2020 Dec; 11(1):6316. PubMed ID: 33298911
[TBL] [Abstract][Full Text] [Related]
5. TRB3 interacts with SMAD3 promoting tumor cell migration and invasion.
Hua F; Mu R; Liu J; Xue J; Wang Z; Lin H; Yang H; Chen X; Hu Z
J Cell Sci; 2011 Oct; 124(Pt 19):3235-46. PubMed ID: 21896644
[TBL] [Abstract][Full Text] [Related]
6. Tripping on TRIB3 at the junction of health, metabolic dysfunction and cancer.
Mondal D; Mathur A; Chandra PK
Biochimie; 2016 May; 124():34-52. PubMed ID: 26855171
[TBL] [Abstract][Full Text] [Related]
7. TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription.
Yu JM; Sun W; Wang ZH; Liang X; Hua F; Li K; Lv XX; Zhang XW; Liu YY; Yu JJ; Liu SS; Shang S; Wang F; Yang ZN; Zhao CX; Hou XY; Li PP; Huang B; Cui B; Hu ZW
Nat Commun; 2019 Dec; 10(1):5720. PubMed ID: 31844113
[TBL] [Abstract][Full Text] [Related]
8. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation.
Zhang XW; Zhou JC; Peng D; Hua F; Li K; Yu JJ; Lv XX; Cui B; Liu SS; Yu JM; Wang F; Jin CC; Yang ZN; Zhao CX; Hou XY; Huang B; Hu ZW
Autophagy; 2020 May; 16(5):782-796. PubMed ID: 31286822
[TBL] [Abstract][Full Text] [Related]
9. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway.
Su J; Yan Y; Qu J; Xue X; Liu Z; Cai H
Oncol Rep; 2017 Mar; 37(3):1565-1572. PubMed ID: 28184934
[TBL] [Abstract][Full Text] [Related]
10. TRIB3 Stabilizes High TWIST1 Expression to Promote Rapid APL Progression and ATRA Resistance.
Lin J; Zhang W; Niu LT; Zhu YM; Weng XQ; Sheng Y; Zhu J; Xu J
Clin Cancer Res; 2019 Oct; 25(20):6228-6242. PubMed ID: 31235507
[TBL] [Abstract][Full Text] [Related]
11. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway.
Hong B; Zhou J; Ma K; Zhang J; Xie H; Zhang K; Li L; Cai L; Zhang N; Zhang Z; Gong K
Int J Biol Sci; 2019; 15(3):587-597. PubMed ID: 30745845
[TBL] [Abstract][Full Text] [Related]
12. TRIB3 facilitates glioblastoma progression via restraining autophagy.
Tang Z; Chen H; Zhong D; Wei W; Liu L; Duan Q; Han B; Li G
Aging (Albany NY); 2020 Nov; 12(24):25020-25034. PubMed ID: 33203798
[TBL] [Abstract][Full Text] [Related]
13. TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations.
Hua F; Li K; Yu JJ; Lv XX; Yan J; Zhang XW; Sun W; Lin H; Shang S; Wang F; Cui B; Mu R; Huang B; Jiang JD; Hu ZW
Nat Commun; 2015 Aug; 6():7951. PubMed ID: 26268733
[TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
[TBL] [Abstract][Full Text] [Related]
15. Mammalian Pseudokinase TRIB3 in Normal Physiology and Disease: Charting the Progress in Old and New Avenues.
Ord T; Ord T
Curr Protein Pept Sci; 2017; 18(8):819-842. PubMed ID: 28393700
[TBL] [Abstract][Full Text] [Related]
16. TRIB3 downregulation enhances doxorubicin-induced cytotoxicity in gastric cancer cells.
Wu IJ; Lin RJ; Wang HC; Yuan TM; Chuang SM
Arch Biochem Biophys; 2017 May; 622():26-35. PubMed ID: 28442401
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer.
Felip I; Moiola CP; Megino-Luque C; Lopez-Gil C; Cabrera S; Solé-Sánchez S; Muñoz-Guardiola P; Megias-Roda E; Pérez-Montoyo H; Alfon J; Yeste-Velasco M; Santacana M; Dolcet X; Reques A; Oaknin A; Rodríguez-Freixinos V; Lizcano JM; Domènech C; Gil-Moreno A; Matias-Guiu X; Colas E; Eritja N
Gynecol Oncol; 2019 May; 153(2):425-435. PubMed ID: 30853360
[TBL] [Abstract][Full Text] [Related]
18. TRIB3 destabilizes tumor suppressor PPARα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia.
Luo X; Zhong L; Yu L; Xiong L; Dan W; Li J; Ye J; Chu X; Liu C; Liu B
Life Sci; 2020 Sep; 257():118021. PubMed ID: 32621919
[TBL] [Abstract][Full Text] [Related]
19. TRIB3 promotes lung cancer progression by activating β-catenin signaling.
Zhang X; Zhong N; Li X; Chen MB
Eur J Pharmacol; 2019 Nov; 863():172697. PubMed ID: 31562867
[TBL] [Abstract][Full Text] [Related]
20. TRIB3 enhances cell viability during glucose deprivation in HEK293-derived cells by upregulating IGFBP2, a novel nutrient deficiency survival factor.
Örd T; Örd D; Adler P; Vilo J; Örd T
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2492-505. PubMed ID: 26094770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]